according to Thai Accounting standard No.12 “Income tax”. However as at 30 September 2017, the Company still has retained deficit to be applied within 5 years from the loss year in the amount of 19.39 million
the financial statements, which effect to accrued income decreased of Baht 690.80 million and deficit increased of Baht 690.74 million in the consolidated statement of financial position as at 31
29.61 428.62 Earnings (deficit) per share (Baht) 0.07 0.97 The company would like to explain the causes of changes as follows: 1. Sales revenues were decreased by 273.07 million baht or 2.93% from
% because the Company re-estimates the performance, so the Company can use the deficit lower than the last year. Net profit (loss) For the year 2018, the Company has net loss at Baht 40 .61 million which
the same quarter of prior year by Baht 0.72 million or equivalent to 65.45%, because the Company re-estimates the performance, so the Company can use the deficit lower than the last year. Net profit
8,467.51 Treasury Shares - - - - Shares Of The Company Held By Subsidiaries - - - - Other Surplus (Deficit) - - - - Premium (Discount) On Share Capital 9,356.23 9,356.23 9,356.23 9,356.23 Retained Earnings
PRI signatories in 2021 New high record of USD 121 trillion collective AUM The rise of sustainable investing & the growing shift to intangible. Thailand perspective: Source: PRI report, Morning Star
their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve
decrease of Baht 42.95 million or down by 7.19% due to the shift of joint marketing activities with suppliers to the second half of this year. 2. Gross profit was Baht 3,847.69 million, an increase of Baht